Gastrointestinal cancer is a large category that includes anal cancer, colon cancer, gallbladder cancer, esophageal cancer, liver cancer, pancreatic cancer, rectal cancer, stomach cancer, and transitional cell carcinoma.
At NewYork-Presbyterian, clinicians offer screening as well as genetic counseling for many types of gastrointestinal cancer. The most well known screening is probably colonoscopy, which enables physicians to identify and remove precancerous lesions called polyps in the colon and rectum before they turn into cancer. Genetic counselors help patients assess their risk of developing gastrointestinal and other types of cancers and make informed decisions about how to reduce their risk and that of other family members.
If cancer is detected, our doctors determine the best treatment approach for each patient by taking into account the type, location, and stage of the disease as well as the patient's age and physical health. Doctors may treat patients with gastrointestinal cancer with surgery, interventional endoscopy, radiation, chemotherapy, immunotherapy, targeted therapies, or a combination of these.
Lastly, NewYork-Presbyterian is a major academic medical center. Our clinicians and laboratory investigators work closely together to identify potential new therapies for gastrointestinal cancers, and we offer patients new, experimental therapies through our clinical trials program.
For more information, please visit the Center for Advanced Digestive Care.